نتائج البحث

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

• Authors : Shogo Amano; Seiji Kaino; Shuhei Shinoda

Subjects: Pancreatic cancer; Iron chelation; Cancer therapy

• Source: BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)

تفاصيل العنوان

Retraction Note: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

• Authors : Shogo Amano; Seiji Kaino; Shuhei Shinoda

Subjects: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282

• Source: BMC Cancer, Vol 23, Iss 1, Pp 1-1 (2023)

تفاصيل العنوان

Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

• Authors : Shogo Amano; Seiji Kaino; Shuhei Shinoda

Subjects: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282

• Source: BMC Cancer, Vol 23, Iss 1, Pp 1-2 (2023)

تفاصيل العنوان

Retraction Note: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox.

• Authors : Amano S; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan.; Kaino S

• Source: BMC cancer [BMC Cancer] 2023 Dec 11; Vol. 23 (1), pp. 1218. Date of Electronic Publication: 2023 Dec 11.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox.

• Authors : Amano S; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan.; Kaino S

Subjects: Cell Movement/Cell Movement/Cell Movement/*drug effects ; Deferasirox/Deferasirox/Deferasirox/*pharmacology ; Iron Chelating Agents/Iron Chelating Agents/Iron Chelating Agents/*pharmacology

• Source: BMC cancer [BMC Cancer] 2020 Jul 22; Vol. 20 (1), pp. 681. Date of Electronic Publication: 2020 Jul 22.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox.

• Authors : Amano S; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan.; Kaino S

• Source: BMC cancer [BMC Cancer] 2023 Jun 23; Vol. 23 (1), pp. 582. Date of Electronic Publication: 2023 Jun 23.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.

• Authors : Hirofumi Harima¹; Seiji Kaino¹ ; Taro Takami¹

• Source: BMC Cancer. 8/31/2016, Vol. 16, p1-11. 11p. 1 Diagram, 2 Charts, 6 Graphs.

تفاصيل العنوان

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

• Authors : Koichi Fujisawa; Hirofumi Harima; Toshihiko Matsumoto

Subjects: rac1 GTP-Binding Protein; Cancer Research; Cancer therapy

• Source: BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)BMC Cancer

تفاصيل العنوان

Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo.

• Authors : Harima H; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan.; Kaino S

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Apoptosis/Apoptosis/Apoptosis/*drug effects ; Benzoates/Benzoates/Benzoates/*pharmacology

• Source: BMC cancer [BMC Cancer] 2016 Aug 31; Vol. 16, pp. 702. Date of Electronic Publication: 2016 Aug 31.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Low oxygen tension reverses antineoplastic effect of iron chelator deferasirox in human glioblastoma cells.

• Authors : Legendre C; INSERM U1066, Micro et Nanomédecines Biomimétiques, IBS - CHU, 4 Rue Larrey, F-49933, Angers, France.; Avril S

Subjects: Cell Hypoxia*; Benzoates/Benzoates/Benzoates/*administration & dosage ; Glioblastoma/Glioblastoma/Glioblastoma/*metabolism

• Source: BMC cancer [BMC Cancer] 2016 Feb 01; Vol. 16, pp. 51. Date of Electronic Publication: 2016 Feb 01.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان